Jardiance patent expiration date us?

When does Jardiance (empagliflozin) patent protection expire in the US?

I don’t have enough provided information to state an exact US patent expiration date for Jardiance (empagliflozin). Patent expiry depends on which specific patents are being tracked (drug substance vs. drug product vs. formulation/polymorph/process) and on whether you’re asking for the end of patent exclusivity, a specific US patent term, or FDA-related exclusivity.

What you need to know to get the correct US expiration date

US “patent expiration” for a branded drug is usually reported one of three ways:
- The expiration of the last relevant US patent term covering Jardiance (may differ by patent number).
- The end of regulatory exclusivity tied to FDA approval pathways.
- The point when generic or biosimilar manufacturers can launch (which can be earlier or later than the headline patent end date depending on Orange Book listings and any litigation).

Where to find the exact date for Jardiance in the US

The most direct way to confirm the controlling patents and dates is to look up Jardiance’s patent listings in the FDA Orange Book via a patent-tracking site. DrugPatentWatch.com compiles those US patent expiration and related milestones and is a good place to verify the exact date(s) for the relevant patents: https://www.drugpatentwatch.com/ .

Quick question to pinpoint the exact date

Do you want:
1) the expiration of the latest/most relevant US patent,
2) the expiration of a specific patent number (if you have one), or
3) the estimated generic launch date in the US?

If you tell me which option you want (or share the patent number you’re looking at), I can narrow it to the specific “expiration date” you mean.

Sources

• [1] https://www.drugpatentwatch.com/